Corporate transparency

High Net Worth Individuals Face a Challenging Wealth Planning Landscape

Retrieved on: 
Wednesday, July 5, 2023

High net worth individuals must pay close attention to new conditions and how they will impact their wealth planning strategies.

Key Points: 
  • High net worth individuals must pay close attention to new conditions and how they will impact their wealth planning strategies.
  • "Given the upcoming changes in tax laws, regulatory environments, and economic conditions, it is vital for high net worth individuals to proactively review and adjust their wealth planning strategies," advises David Frederick, J.D., LL.M.
  • High net worth individuals using these structures for asset protection and confidentiality will need to adapt to new regulations, potentially with high administration costs and lower privacy protections.
  • To navigate this increasingly complex landscape, high net worth individuals are strongly encouraged to seek guidance from experienced estate planning professionals.

Harrow Health Publishes Corporate Transparency Report

Retrieved on: 
Tuesday, February 8, 2022

Harrow Health, Inc. (Nasdaq: HROW), an ophthalmicfocused healthcare company, today announced that its inaugural 2022 Corporate Transparency Report is now available under the Investors section of the Companys website, harrowinc.com .

Key Points: 
  • Harrow Health, Inc. (Nasdaq: HROW), an ophthalmicfocused healthcare company, today announced that its inaugural 2022 Corporate Transparency Report is now available under the Investors section of the Companys website, harrowinc.com .
  • Simply put, this is a report card of why each member of the Harrow family is proud to be a part of what we do each and every day, said Mark L. Baum, Chief Executive Officer of Harrow Health.
  • Harrow Health also holds noncontrolling equity positions in Eton Pharmaceuticals , Surface Ophthalmics and Melt Pharmaceuticals , all of which started as Harrow Health subsidiaries, and owns royalty rights in four clinicalstage drug candidates being developed by Surface Ophthalmics and Melt Pharmaceuticals.
  • For more information about Harrow Health, please visit the Investors section of the corporate website, www.harrowinc.com .

Wolters Kluwer CT Corporation Podcast Navigates Evolving Corporate Transparency Act Requirements

Retrieved on: 
Monday, January 24, 2022

But, according to a new installment of Wolters Kluwer CT Corporations recently launched CT Expert Insights Podcast , there remain some unanswered questions for organizations looking to comply.

Key Points: 
  • But, according to a new installment of Wolters Kluwer CT Corporations recently launched CT Expert Insights Podcast , there remain some unanswered questions for organizations looking to comply.
  • However, CT Corporation has been tracking the development of the Corporate Transparency Act since it was passed in January 2021 and will continue to provide additional guidance as progress develops.
  • For nearly 130 years, Wolters Kluwer CT Corporation has been the leading provider of registered agent services, incorporation services, and legal entity compliance.
  • The other legal services business of Wolters Kluwer GRC is Wolters Kluwer ELM Solutions a global provider of enterprise legal spend and matter management, contract lifecycle management and legal analytics solutions.